we strive to develop patient-centered and
novel therapeutics with
cutting-edge science and technology
Who we are
Simnova is a clinical stage biotech company focusing on the development of therapy for cancer treatment.
Leadership Team
-
.jpg)
Cao Zhuoxiao
M.D., Ph.D.
CEO -
Wen Limin
M.D. , Ph.D.
Clinical SVP -
.jpg)
Dr. Wang Pin
Tenured Prof. of USC
Scientific Advisor -
Dr. Tamas Oravecz
CSO, U.S. of Simcere
Scientific Advisor
Our History
-
-
-
2019
Established in
Cambridge MA,USA
-
-
-
-
2020
GMP facility completed in
Shanghai
-
-
-
-
2021
Simnova spun off from
Simcere to become an
independent company
-
-
-
-
2022
The first product of the allogeneic CAR-NK platform has entered clinical stage
The first product of double CAR-BiTE autologous CAR-T platform for solid tumor has entered clinical stage
BCMA CAR-T program started clinical trial initiated
-